Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-390508 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,536
Total Value
$309,506.33
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Sep 10, 2026 | Sale | 9,525 | $32.46 | $309,139.59 | 190,849 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 10, 2026 | Sale | 11 | $33.34 | $366.74 | 190,838 | Direct | โ | View Details |